MichBio Expo Talks Biofuels, Pharma, Medical DevicesThe eighth annual MichBio Expo wasn't all about new drugs and medical devices. Biotech also means biofuels, a Thursday morning panel discussion noted.
Perrigo Reports Record First Quarter Revenue, EarningsThe Allegan-based generic drug and health products manufacturer Perrigo Co. (Nasdaq: PRGO) Wednesday reported net income of $106 million or $1.12 a share in the first fiscal quarter ended Sept. 29, up from $70.5 or 75 cents a share in the same quarter a year earlier.
Livonia Drug Firm Makes BuyThe Harvard Drug Group LLC of Livonia said its Major Pharmaceuticals division has purchased the Rugby over-the-counter pharmaceutical products and trademarks from Parsippany, N.J.-based Watson Pharmaceuticals Inc. (NYSE: WPI) for $117 million.
Perrigo Sales, Profits Both Jump 15 Percent For Fiscal YearThe generic drug and store-brand health and beauty products maker Perrigo Co. (Nasdaq: PRGO) Thursday reported net income fo $393 million or $4.18 a share in its fiscal year ended June 30, up 15 percent from $340.6 million or $3.64 a share in the prior fiscal year.
Ann Arbor's NSF Buys D.C.-Based FDA Consulting FirmNSF International, an independent global public health and safety organization which develops standards as well as tests and certifies products for the food, water, health and consumer products industries, has acquired Becker & Associates Consulting Inc., a clinical, regulatory and scientific consulting firm that specializes in U.S. Food and Drug Administration-regulated industries, specifically medical devices, pharmaceuticals and biologics.
Adeona Loss Grows, But Other Markers HappierThe Ann Arbor pharma startup Adeona Pharmaceuticals Inc. (Amex: AEN) this week reported a larger loss but also larger sales and more positive developments for the first quarter ended March 31.
Health Care Industry Consultant Sees Bright Future For MichiganA longtime Detroit-area business consulting firm has added a health care practice and hired a veteran of the industry to lead its efforts among pharmaceutical and medical device companies
Lycera Announces Research Collaboration with MerckThe Plymouth-based biopharmaceutical developer Lycera Corp. Thursday announced an exclusive research collaboration with pharma giant Merck to develop drug candidates that have the potential to treat major autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis
Event Notices From January 18The latest event and meeting notices from Michigan's technology community, before they're posted on the GLITR IT Calendar
Caraco Gets Sun Pharma Offer To Go PrivateDetroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) has received an offer to go private from its parent company and India.
Pharma Web Sites Top Hospital, Health Insurance Sites in Customer Satisfaction
Kalamazoo Pharma Firm To Present Advance In Obesity Treatment